Darapladib | Interleukin Related interleukin-related.com

Product Name :
Darapladib

Search keywords :
Darapladib

drugId :
null

Target Vo:
Lipoprotein-associated phospholipase A2

Target Vo Short Name :
Lp-PLA2

Moa_Name:
Lipoprotein-associated phospholipase A2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Glaxosmithkline Plc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Atherosclerosis

Termination Status :
Phase 3 Clinical

China Termination Status :
Phase 3 Clinical

Highest Status:
Pending

China Highest Status:
Pending

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cofetuzumab pelidotin Cancer
IRF3 Rabbit mAb site
Galectin 1 Antibody: Galectin 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Galectin 1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts